Level Four Advisory Services’s Genmab GMAB Stock Holding History

Level Four Advisory Services’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.59M	Buy	58,000 +977	+2%	+$26K	0.05%	351
2026 Q1	$1.53M	Sell	57,023 -4,004	-7%	-$120K	0.05%	340
2025 Q4	$1.88M	Sell	61,027 -6,316	-9%	-$197K	0.06%	291
2025 Q3	$2.07M	Buy	67,343 +2,418	+4%	+$58.9K	0.07%	271
2025 Q2	$1.34M	Buy	64,925 +12,888	+25%	+$265K	0.05%	327
2025 Q1	$1.02M	Buy	52,037 +35,417	+213%	+$743K	0.04%	337
2024 Q4	$347K	Sell	16,620 -25,668	-61%	-$564K	0.01%	580
2024 Q3	$944K	Buy	42,288 +30,076	+246%	+$804K	0.04%	367
2024 Q2	$307K	Buy	12,212 +5,271	+76%	+$149K	0.01%	603
2024 Q1	$221K	Hold	6,941	–	–	0.01%	694
2023 Q4	$221K	Sell	6,941 -2,241	-24%	-$70.4K	0.01%	690
2023 Q3	$324K	Sell	9,182 -503	-5%	-$19.2K	0.02%	557
2023 Q2	$368K	Buy	9,685 +1,053	+12%	+$42K	0.02%	566
2023 Q1	$326K	Buy	8,632 +2,043	+31%	+$78.5K	0.02%	566
2022 Q4	$279K	Sell	6,589 -2,953	-31%	-$122K	0.02%	534
2022 Q3	$307K	Sell	9,542 -28	-0.3%	-$983	0.03%	429
2022 Q2	$311K	Sell	9,570 -1,466	-13%	-$47.5K	0.03%	444
2022 Q1	$399K	Buy	+11,036	New	+$379K	0.03%	453
2021 Q4	–	Sell	-8,595	Closed	-$376K	–	662
2021 Q3	$376K	Buy	+8,595	New	+$386K	0.04%	344

Other funds holding GMAB

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Level Four Advisory Services's GMAB Position: Q2 2026 in Review

Level Four Advisory Services increased its Genmab (GMAB) stake by 1.7% in Q2 2026, buying an estimated $26K and bringing the position to 58,000 shares worth $1.59M. The position accounts for 0.05% of the portfolio, ranked #351.

Level Four Advisory Services first reported a position in GMAB in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.07M in Q3 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

Level Four Advisory Services held 58,000 shares of Genmab worth $1.59M as of Q2 2026.
Level Four Advisory Services bought 977 Genmab shares in Q2 2026, an estimated $26K.
Genmab made up 0.05% of Level Four Advisory Services's portfolio in Q2 2026, its #351 holding.
Level Four Advisory Services first reported a position in Genmab in Q3 2021 and has held it in 19 quarters since.
Level Four Advisory Services's Genmab position peaked at $2.07M in Q3 2025.
289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Level Four Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.